Literature DB >> 24654255

Ocular and skin manifestations in systemic pseudohypoaldosteronism.

Mahmoud Salah Eliwa1, Aymen Hussein El-Emmawie, Mahmood Ahmad Saeed.   

Abstract

Pseudohypoaldosteronism type-1 is a rare disorder characterised by end-organ resistance to aldosterone resulting in salt-losing crisis with hyponatraemic dehydration, hyperkalaemia and metabolic acidosis. We report two siblings with pseudohypoaldosteronism type-1 who presented early in neonatal period with hyponatraemia, severe hyperkalaemia and metabolic acidosis. Both babies had miliaria like skin rash which flared up during episodes of hyperkalaemia and hyponatraemia. They had visible dilated meibomian glands from which a white material was protruding. The clinical presentation of pseudohypoaldosteronism type-1 mimics congenital adrenal hyperplasia. As there is often a delay in obtaining hormonal assay results, the eye and skin manifestations may give an important diagnostic clue which in turn will influence management.

Entities:  

Mesh:

Year:  2014        PMID: 24654255      PMCID: PMC3962973          DOI: 10.1136/bcr-2014-203741

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  5 in total

1.  Unique eyelid manifestations in type 1 pseudohypoaldosteronism.

Authors:  Arwa Nasir; Issam Abou Najab
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2012-11       Impact factor: 5.747

2.  Pustular miliaria rubra: a specific cutaneous finding of type I pseudohypoaldosteronism.

Authors:  Amy Urbatsch; Amy S Paller
Journal:  Pediatr Dermatol       Date:  2002 Jul-Aug       Impact factor: 1.588

Review 3.  Clinical and molecular features of type 1 pseudohypoaldosteronism.

Authors:  Felix G Riepe
Journal:  Horm Res       Date:  2009-06-30

4.  Pseudohypoaldosteronisms, report on a 10-patient series.

Authors:  Alexandre Belot; Bruno Ranchin; Christine Fichtner; Lucie Pujo; Bernard C Rossier; Aurélia Liutkus; Claud Morlat; Marc Nicolino; Maria C Zennaro; Pierre Cochat
Journal:  Nephrol Dial Transplant       Date:  2008-05       Impact factor: 5.992

5.  Case report: severe neonatal hyperkalemia due to pseudohypoaldosteronism type 1.

Authors:  Bahareh Schweiger; Margaret W Moriarty; Melissa A Cadnapaphornchai
Journal:  Curr Opin Pediatr       Date:  2009-04       Impact factor: 2.856

  5 in total
  4 in total

1.  Loss of β Epithelial Sodium Channel Function in Meibomian Glands Produces Pseudohypoaldosteronism 1-Like Ocular Disease in Mice.

Authors:  Dongfang Yu; Yogesh Saini; Gang Chen; Andrew J Ghio; Hong Dang; Kimberlie A Burns; Yang Wang; Richard M Davis; Scott H Randell; Charles R Esther; Friedrich Paulsen; Richard C Boucher
Journal:  Am J Pathol       Date:  2017-10-26       Impact factor: 4.307

2.  Dermal and Ophthalmic Findings in Pseudohypoaldosteronism.

Authors:  Sabriye Korkut; Emir Gökalp; Ahmet Özdemir; Selim Kurtoğlu; Şafak Demirtaş; Ülkü Gül; Osman Baştuğ
Journal:  J Clin Res Pediatr Endocrinol       Date:  2015-06

3.  Novel SCNN1A gene splicing-site mutation causing autosomal recessive pseudohypoaldosteronism type 1 (PHA1) in two Italian patients belonging to the same small town.

Authors:  Gregorio Serra; Vincenzo Antona; Maria Michela D'Alessandro; Maria Cristina Maggio; Vincenzo Verde; Giovanni Corsello
Journal:  Ital J Pediatr       Date:  2021-06-16       Impact factor: 2.638

4.  Characterization of Rat Meibomian Gland Ion and Fluid Transport.

Authors:  Dongfang Yu; Richard M Davis; Megumi Aita; Kimberlie A Burns; Phillip W Clapp; Rodney C Gilmore; Michael Chua; Wanda K O'Neal; Richard Schlegel; Scott H Randell; Richard C Boucher
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-04-01       Impact factor: 4.799

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.